SC1-BHC-28-2019
SC1-BHC-28-2019
9 projects · €105,846,175 total EU contribution (project-level) · 143 participating organizations · 25 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€105,846,175
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (19)
- Netherlands (17)
- FI (12)
- Germany (10)
- France (10)
- DK (8)
- Spain (8)
- BE (7)
- Italy (7)
- SE (7)
- EL (5)
- NO (5)
- US (5)
- CH (4)
- AT (3)
- CZ (3)
- PL (3)
- EE (2)
- HU (2)
- CY (1)
- LT (1)
- MK (1)
- PT (1)
- RO (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM5 projects · FR
- ISGLOBAL4 projects · ES
- KI4 projects · SE
- NORWEGIAN INSTITUTE OF PUBLIC HEALTH NIPH3 projects · NO
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3 projects · UK
- KU Leuven3 projects · BE
- UOULU3 projects · FI
- UU3 projects · NL
- AU2 projects · DK
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN2 projects · NL
- IARC2 projects · FR
- CNRS2 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Human Exposome Assessment Platform HEAP · 874662 | H2020 | €11,996,515 | €518,875 | Details |
Exposome project for health and occupational research EPHOR · 874703 | H2020 | €11,981,852 | €651,475 | Details |
Early Environmental quality and life-course mental health effects Equal-Life · 874724 | H2020 | €11,994,426 | €591,150 | Details |
Advancing Tools for Human Early Lifecourse Exposome Research and Translation ATHLETE · 874583 | H2020 | €11,998,334 | €312,500 | Details |
Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases LONGITOOLS · 874739 | H2020 | €11,997,449 | €427,941 | Details |
EXposome Powered tools for healthy living in urbAN SEttings EXPANSE · 874627 | H2020 | €11,993,907 | €75,000 | Details |
Impact of exposome on the course of lung diseases REMEDIA · 874753 | H2020 | €11,013,022 | €331,125 | Details |
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome EXIMIOUS · 874707 | H2020 | €10,878,331 | €664,875 | Details |
Human Exposomic Determinants of Immune Mediated Diseases HEDIMED · 874864 | H2020 | €11,992,339 | €0 | Details |
